Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185982 |
APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185985 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-09 | 2023-04-06 | 186575 |
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-16 | 2023-04-06 | 187238 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-06 | 2023-04-21 | 188973 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-14 | 2024-02-02 | 189647 |
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-29 | 190874 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-06 | 2023-06-09 | 191880 |
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-06 | 2023-05-12 | 191898 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-07-21 | 192800 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-19 | 2023-06-23 | 192818 |
APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-05-26 | 2023-07-21 | 193218 |
APO-OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-02 | 2023-08-12 | 193614 |
APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-09 | 2023-09-22 | 194571 |
APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-08-04 | 195091 |
APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-23 | 196297 |
APO-FELODIPINE | 10MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-04 | 196300 |
APO-OXYCODONE CR | 80.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-12 | 196312 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-07-21 | 2023-08-04 | 199527 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2023-07-27 | 2024-03-15 | 200177 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |